Guidelines for Centers for AIDS Research (CFAR) Projects
For any clinical research studies above minimal risk or in vulnerable populations.
HIV Extinction Project
The UCLA AIDS Institute is accepting applications for novel and highly innovative seed grants to fund basic, clinical and/or translational studies related to HIV Cure research with special emphasis on collaborative and multi-disciplinary studies. Cure research is defined here as lifelong suppression or elimination of HIV-1 in the absence of cART. This RFA will support research focused on the NIH aims of achieving “sustained viral remission, and, in the longer term, viral eradication.” Research to be funded under this RFA includes, but is not limited to, understanding how the HIV reservoir forms, persists and reactivates, as well as research into novel approaches for targeting of HIV reservoirs including therapeutic vaccines, development of genetically engineered immune cells that are resistant to HIV infection, drugs that reactivate the latent reservoir, cure-inducing immunotherapies and treatments to silence HIV in infected cells.
Basic and Translational Virology Research
The UCLA AIDS Institute and I3T are accepting Letters of Intent for novel seed grant proposals from the field of virology. Applicants are invited to submit proposals addressing fundamental processes that can be used to identify common themes relevant to viruses that will ultimately impact our understanding of HIV disease. These processes could include, but are not limited to: viral replication, cellular innate responses, immune evasion and defense, viral evolution, therapeutic interventions etc. All applications must be focused on studies of viruses other than HIV, but potential relevance to HIV must be shown. Funding will be expected to facilitate development of preliminary data that can be leveraged for future submissions of R01 or program project grants.
Applicants whose Letters of Intents are favorably reviewed will be invited to submit a formal proposal. Formal proposals will then be due on January 13, 2020.
For additional information, please contact Jina Lee at 310-794-5335 or jinalee@mednet.ucla.edu
